Keywords: glaxosmithkline, sees, eps, rise, sales, growth, world
GlaxoSmithKline sees 10% EPS rise on 6% sales growth
Article | 01 August 2005
GlaxoSmithKline, the world's second largest pharmaceutical company, posted a 6% rise in second-quarter 2005 turnover at L5.25 billion ($9.17 billion), with operating profit ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Elan puts up formal "for sale" notice
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
